1 option
Aging in Ophthalmology.
- Format:
- Book
- Author/Creator:
- Alió, Jorge L.
- Language:
- English
- Physical Description:
- 1 online resource (508 pages)
- Edition:
- 1st ed.
- Place of Publication:
- Chantilly : Elsevier Science & Technology, 2025.
- Summary:
- Aging in Ophthalmology examines the aging process of the eye and how this affects the future of ophthalmology.With a strong focus on therapeutic options, the book shows the latest improvements in medical and surgical possibilities.
- Contents:
- Front Cover
- Front Matter
- Titlepage
- Copyright
- Contents
- Contributors
- Preface
- Reference
- Acknowledgments
- Chapter 1 Aging as a risk factor in eye disease: Mechanisms of aging in the human body
- Core Messages
- 1.1 Introduction
- 1.1.1 DNA damage
- 1.1.2 Telomere shortening
- 1.1.3 Epigenetic alterations
- 1.1.4 Mitochondrial dysfunction
- 1.1.5 Reactive oxygen species
- 1.1.6 Cellular senescence
- 1.1.7 Age-related physiological changes
- 1.1.8 Diet and nutrition
- 1.1.9 Physical activity
- 1.1.10 Smoking and alcohol consumption
- 1.1.11 Social and psychological factors
- 1.1.12 Environmental exposures
- 1.2 Ocular embryology and age-related changes
- 1.2.1 Cornea
- 1.2.2 Lens
- 1.2.3 Vitreous
- 1.2.4 Retina
- 1.2.5 Sclera and uvea
- 1.3 Reactive oxygen species
- 1.3.1 The molecular mechanisms of reactive oxygen species
- 1.3.2 Here are a few examples of reactive oxygen species damage in different structures of the eye
- 1.4 Ultraviolet radiation
- 1.4.1 Types of ultraviolet radiation
- 1.4.2 The impact of ultraviolet radiation on ocular health
- 1.5 Genetics and epigenetics and their influence on aging
- 1.5.1 Genetic influences and their clinical implications
- 1.5.2 Epigenetic influences and clinical relevance
- 1.5.3 Genetics and its impact on ocular health
- 1.6 Take-home messages
- References
- Chapter 2 Age-related changes of the eyelid and surgery of eyelids in aging
- Core messages
- 2.1 Eyelid aging
- 2.1.1 Principles of eyelid aging
- 2.1.2 Ligament changes
- 2.1.3 Periosteal changes
- 2.1.4 Contour and shapes
- 2.2 Upper eyelids and brows aging
- 2.2.1 Upper dermatochalasis
- 2.2.2 Ptosis
- 2.2.3 Brow ptosis
- 2.2.4 Floppy eyelid
- 2.3 Lower eyelid aging
- 2.3.1 Lower eyelid dermatochalasis
- 2.3.2 Entropion
- 2.3.3 Ectropion
- 2.3.4 Eyelid tumors.
- Take home notes
- Chapter 3 Age-related changes in the optics of the human eye
- 3.1 Biometric changes
- 3.1.1 Corneal power
- 3.1.2 Crystalline lens
- 3.1.4 Anterior chamber
- 3.1.5 Pupil diameter
- 3.2 Refractive errors and wavefront aberrations
- 3.2.1 Refractive errors
- 3.2.2 Wavefront aberrations
- 3.2.3 Accommodation and presbyopia
- 3.3 Eye models
- 3.4 Photometry
- 3.4.1 Transmittance
- 3.4.2 Straylight
- 3.4.3 Stiles-Crawford effect
- Take home notes
- Chapter 4 Cornea aging: A layered perspective
- 4.1 Introduction
- 4.2 The tear film and corneal epithelium
- 4.2.1 Tear film
- 4.2.2 Corneal epithelium
- 4.2.3 Epithelial basement membrane
- 4.3 Corneal stroma and bowman layer
- 4.3.1 Composition
- 4.3.2 Aging effects
- 4.4 Corneal nerves
- 4.4.1 Function and anatomy
- 4.4.2 Age-related changes
- 4.4.3 Impact on tear production and wound healing
- 4.5 Descemet membrane and endothelium
- 4.5.1 Descemet membrane
- 4.5.2 Corneal endothelium
- 4.6 Age-related changes in corneal physiology, topography, and optics
- 4.6.1 Corneal elasticity and biomechanics
- 4.6.2 Age-related corneal shape changes and optical aberrations
- Take Home Notes
- Chapter 5 Aging in the human lens
- 5.1 Introduction
- 5.1.1 Human lens and crystallin proteins
- 5.1.2 Oxidative stress and antioxidant defense
- 5.1.3 Antioxidant imbalance and ocular health
- 5.1.4 Biomarkers in oxidative stress-related ocular diseases
- 5.2 Cataract pathogenesis and oxidative stress
- 5.2.1 Oxidative Stress-related damage
- 5.2.2 Mechanisms of lens protein oxidation
- 5.2.3 Cellular responses to oxidative stress
- 5.2.4 Impact on antioxidant systems
- 5.3 Optical consequence
- 5.3.1 Densitometric changes and optical quality.
- 5.3.2 Increased scattering and aberrations
- 5.3.3 Aberrometric changes with aging
- 5.4 Predictive diagnostics in oxidative stress-related lens aging
- 5.4.1 Lens
- 5.4.2 Aqueous humor
- 5.4.3 Serum
- 5.5 Prevention and natural antioxidant therapy for oxidative stress-related lens diseases
- Chapter 6 Aging and accommodation
- 6.1 Introduction
- 6.2 Accommodation performance as a function of age
- 6.2.1 Amplitude of accommodation
- 6.2.2 The steady-state response/stimulus relationship
- 6.2.3 Stability of the response
- 6.2.4 Response dynamics
- 6.3 The mechanism of accommodation and its ageing
- 6.3.1 The physiological basis of accommodation
- 6.4 Presbyopia
- 6.4.1 The lens and its capsule
- 6.4.2 The ciliary muscle
- 6.4.3 Zonule
- 6.4.4 Choroid and iris
- 6.4.5 Vitreous
- 6.5 The nonsurgical treatment of presbyopia
- 6.5.1 Delaying the onset of presbyopia
- 6.5.2 Pharmacological improvement in the amplitude of accommodation
- 6.5.3 Improved lighting
- 6.6 Optical correction of presbyopia^^e2^^80^^93fundamentals
- 6.6.1 Spectacle lenses
- 6.6.2 Multifocal spectacle lenses
- 6.6.3 Progressive addition lenses
- 6.6.4 Variable-power lenses
- 6.6.5 Contact lenses
- 6.7 Surgical treatment of presbyopia
- 6.7.1 Refractive lens exchange
- 6.7.2 Cataract surgery
- 6.8 Conclusion
- 6.9 Take-home notes
- Chapter 7 Aging in the trabecular meshwork
- 7.1 Anatomy of the trabecular meshwork
- 7.2 Physiology of the trabecular pathway
- 7.3 Age-related modifications of the trabecular meshwork
- 7.3.1 Cellularity
- 7.3.2 Metabolism and cellular phenotypes
- 7.3.3 Autophagy
- 7.3.4 Changes in biomechanics
- 7.4 Conclusion
- Take-home notes
- Chapter 8 Aging in glaucoma surgery
- 8.1 Introduction.
- 8.2 Relevant age-related changes in the eye for glaucoma surgery
- 8.3 Surgical considerations in the elderly
- 8.3.1 Patient selection
- 8.3.2 Surgical options
- 8.3.3 Type of anesthesia
- 8.4 Postoperative management and outcomes
- 8.4.1 Complications
- 8.4.2 Follow-up and long-term care
- 8.5 Conclusion
- Chapter 9 The aging vitreous gel
- 9.1 Introduction
- 9.2 Once formed the vitreous gel cannot be renewed
- 9.3 Vitreous liquefaction and loss of function
- 9.4 A new function of the vitreous gel
- 9.5 Is the gel important?
- 9.6 Vitreous liquefaction and primary open angle glaucoma
- 9.7 Vitreous liquefaction and loss of structure
- 9.8 Floaters
- 9.9 Retinal complications of posterior vitreous detachment requiring vitrectomy surgery
- 9.10 Conclusion
- Take home note
- Chapter 10 Aging of the human retina
- 10.1 Structural changes
- 10.1.1 Outer retina
- 10.1.2 Inner retina
- 10.2 Molecular and metabolic changes
- 10.2.1 Genome instability
- 10.2.2 Epigenome
- 10.2.3 Dysregulated metabolic signaling
- 10.2.4 Mitochondrial damage
- 10.2.5 Metabolic stress
- 10.2.6 Proteostasis
- 10.2.7 Immunology
- 10.3 Spatial variation of normal age-related changes in individual retinal layers
- 10.3.1 Inner plexiform layer, inner nuclear layer, and outer plexiform layer (Fig. 10.4)
- 10.3.2 Outer nuclear layer, photoreceptor inner/outer segments, and retinal pigment epithelium (Fig 10.5)
- 10.3.3 Retinal nerve fiber layer and ganglion cell layer (Fig. 10.6)
- Chapter 11 Aging of the retinal pigment epithelium
- 11.1 Introduction
- 11.2 Functions of the retinal pigment epithelium
- 11.3 Effect of Age on photoreceptor outer-segment phagocytosis.
- 11.4 Autophagy and the aging retinal pigment epithelium
- 11.5 Effect of Age on lc3-associated phagocytosis in the retinal pigment epithelium
- 11.6 The effect of age on lipofuscin accumulation within the retinal pigment epithelium
- 11.7 The effect of age on bruch's membrane
- 11.8 The effect of age on rpe-mediated ocular immune regulation
- 11.9 Aging and epigenetic changes in the retinal pigment epithelium
- 11.10 Therapies that abrogate age-induced changes to the retinal pigment epithelium
- 11.11 Conclusions
- Funding information
- Chapter 12 Eye and major age-related central nervous system degenerative disorders
- Illustrations
- 12.1 Introduction
- 12.1.1 Overview of central nervous system degenerative disorders
- 12.1.2 Eye anatomy and function
- 12.1.3 Link between eye and central nervous system disorders
- 12.2 Alzheimer's disease and the eye
- 12.2.1 Disease overview
- 12.2.2 Parkinson's disease and the eye
- 12.2.3 Other age-related neurodegenerative disorders and the eye
- 12.2.4 Summary
- 12.2.5 Future outlook
- Chapter 13 Eye and major age-related cardiovascular disorders
- Introduction
- 13.1 Aging in ocular microvascular system
- 13.2 Cardiovascular diseases and ocular microvascular system
- 13.2.1 Cardiovascular diseases risk factors and ocular microvascular system
- 13.2.2 Cardiovascular disease prediction and ocular microvascular system
- 13.3 Aging beyond ocular microvascular system
- 13.4 Cardiovascular diseases beyond ocular microvascular system
- 13.4.1 Cardiovascular diseases risk factors through the eye with AI
- 13.4.2 Cardiovascular diseases prediction through the eye with AI
- 13.5 Clinical application of eye-cardiovascular relationship
- 13.5.1 Vascular aging monitoring.
- 13.5.2 Disease risk stratification.
- Notes:
- Description based on publisher supplied metadata and other sources.
- ISBN:
- 0-443-13984-9
- OCLC:
- 1539039568
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.